BRPI0917290A8 - Composição imunológica - Google Patents
Composição imunológicaInfo
- Publication number
- BRPI0917290A8 BRPI0917290A8 BRPI0917290A BRPI0917290A BRPI0917290A8 BR PI0917290 A8 BRPI0917290 A8 BR PI0917290A8 BR PI0917290 A BRPI0917290 A BR PI0917290A BR PI0917290 A BRPI0917290 A BR PI0917290A BR PI0917290 A8 BRPI0917290 A8 BR PI0917290A8
- Authority
- BR
- Brazil
- Prior art keywords
- antigen
- immunological
- compositions
- virus
- immune response
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title abstract 8
- 230000001900 immune effect Effects 0.000 title abstract 7
- 239000000427 antigen Substances 0.000 abstract 5
- 102000036639 antigens Human genes 0.000 abstract 5
- 108091007433 antigens Proteins 0.000 abstract 5
- 241000120506 Bluetongue virus Species 0.000 abstract 3
- 241000712462 Bovine ephemeral fever virus Species 0.000 abstract 3
- 230000028993 immune response Effects 0.000 abstract 3
- 241001465754 Metazoa Species 0.000 abstract 2
- 241000283690 Bos taurus Species 0.000 abstract 1
- 241000701083 Bovine alphaherpesvirus 1 Species 0.000 abstract 1
- 229920000858 Cyclodextrin Polymers 0.000 abstract 1
- 241001644525 Nastus productus Species 0.000 abstract 1
- 241000700605 Viruses Species 0.000 abstract 1
- UZQJVUCHXGYFLQ-AYDHOLPZSA-N [(2s,3r,4s,5r,6r)-4-[(2s,3r,4s,5r,6r)-4-[(2r,3r,4s,5r,6r)-4-[(2s,3r,4s,5r,6r)-3,5-dihydroxy-6-(hydroxymethyl)-4-[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-3,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-3,5-dihydroxy-6-(hy Chemical compound O([C@H]1[C@H](O)[C@@H](CO)O[C@H]([C@@H]1O)O[C@H]1[C@H](O)[C@@H](CO)O[C@H]([C@@H]1O)O[C@H]1CC[C@]2(C)[C@H]3CC=C4[C@@]([C@@]3(CC[C@H]2[C@@]1(C=O)C)C)(C)CC(O)[C@]1(CCC(CC14)(C)C)C(=O)O[C@H]1[C@@H]([C@@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O[C@H]4[C@@H]([C@@H](O[C@H]5[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O5)O)[C@H](O)[C@@H](CO)O4)O)[C@H](O)[C@@H](CO)O3)O)[C@H](O)[C@@H](CO)O2)O)[C@H](O)[C@@H](CO)O1)O)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O UZQJVUCHXGYFLQ-AYDHOLPZSA-N 0.000 abstract 1
- 230000001681 protective effect Effects 0.000 abstract 1
- 239000001397 quillaja saponaria molina bark Substances 0.000 abstract 1
- 229930182490 saponin Natural products 0.000 abstract 1
- 150000007949 saponins Chemical class 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/716—Glucans
- A61K31/724—Cyclodextrins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
- A61P31/22—Antivirals for DNA viruses for herpes viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5252—Virus inactivated (killed)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55505—Inorganic adjuvants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55577—Saponins; Quil A; QS21; ISCOMS
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55583—Polysaccharides
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Virology (AREA)
- Epidemiology (AREA)
- Immunology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Molecular Biology (AREA)
- Organic Chemistry (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicinal Preparation (AREA)
- Peptides Or Proteins (AREA)
Abstract
COMPOSIÇÃO IMUNOLÓGICA. A presente invenção refere-se a composições imunológicas compreendendo sulfolipo-ciclodextrina (SL-CD) e, saponina ou QuilA, e opcionalmente pelo menos um antígeno. A invenção refere-se a métodos e composições imunológicas compreendendo pelo menos um antígeno, que pode ser um antígeno veterinário. O antígeno veterinário nos métodos e composições imunológicas da invenção pode ser um antígeno bovino. A invenção refere-se a métodos e composições imunológicas compreendendo vírus da febre efêmera bovina (BEFV), vírus de herpes bovino 1 (IBR) ou vírus da língua azul (BTV). A invenção compreende métodos de obter uma resposta imune contra BEFV, IBR, ou BTV em um animal, que compreende administrar ao animal uma composição da invenção. Na invenção, particularmente a resposta imune é uma resposta imune protetora. A invenção compreende um método de preparar uma composição imunológica compreendendo adicionar Quil A a um vírus.
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| AU2008904261A AU2008904261A0 (en) | 2008-08-19 | Immunological Composition | |
| US9209108P | 2008-08-27 | 2008-08-27 | |
| PCT/US2009/054285 WO2010022135A1 (en) | 2008-08-19 | 2009-08-19 | Immunological composition |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| BRPI0917290A2 BRPI0917290A2 (pt) | 2015-11-10 |
| BRPI0917290A8 true BRPI0917290A8 (pt) | 2016-11-01 |
Family
ID=41696586
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BRPI0917290A BRPI0917290A8 (pt) | 2008-08-19 | 2009-08-19 | Composição imunológica |
Country Status (16)
| Country | Link |
|---|---|
| US (1) | US20100047279A1 (pt) |
| EP (1) | EP2331126A1 (pt) |
| JP (1) | JP2012500282A (pt) |
| KR (1) | KR101320141B1 (pt) |
| CN (1) | CN102186502B (pt) |
| AR (1) | AR076437A1 (pt) |
| AU (1) | AU2009282581B2 (pt) |
| BR (1) | BRPI0917290A8 (pt) |
| CA (1) | CA2734654C (pt) |
| CO (1) | CO6341568A2 (pt) |
| MX (1) | MX2011001910A (pt) |
| RU (1) | RU2506094C2 (pt) |
| TW (1) | TW201010719A (pt) |
| UA (1) | UA101385C2 (pt) |
| WO (1) | WO2010022135A1 (pt) |
| ZA (1) | ZA201102082B (pt) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MX2012004133A (es) * | 2009-10-07 | 2012-05-08 | Wyeth Llc | Composiciones que comprenden adyuvante, macrolido y antigeno proteico y procedimientos de uso de las mismas. |
| WO2011112945A2 (en) * | 2010-03-12 | 2011-09-15 | Merial Limited | Foot and mouth disease virus recombinant vaccines and uses thereof |
| US20140086961A1 (en) * | 2011-05-09 | 2014-03-27 | Universitat Autonoma De Barcelona | Use of cyclodextrins in diets, water or vaccine adjuvants to boost the immune system of fish |
| CN103083658B (zh) * | 2011-10-27 | 2015-09-02 | 普莱柯生物工程股份有限公司 | 一种用于治疗或预防猪感染性疾病的疫苗佐剂组合物 |
| EP3057613A1 (en) | 2013-10-17 | 2016-08-24 | Zoetis Services LLC | Methods and compositions for treatment of s. equi infection |
| EP3145522B1 (en) * | 2014-05-23 | 2020-12-23 | Phibro Animal Health Corporation | Combination, composition, and method of administering the combination or composition to animals |
| BR102021012953A2 (pt) * | 2021-06-29 | 2023-01-10 | Fabp Biotech Desenvolvimento Em Biotecnologia Ltda. | Composição de vacina veterinária contra helmintos, método para tratamento e prevenção de infecção causada por helmintos e uso |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DK316188A (da) * | 1987-06-15 | 1988-12-16 | Duphar Int Res | Sulfolipopolysaccharider som stimolatorer for den ikke specifikke forsvarsmekanisme |
| GB9622159D0 (en) * | 1996-10-24 | 1996-12-18 | Solvay Sociutu Anonyme | Polyanionic polymers as adjuvants for mucosal immunization |
| AU734180B2 (en) * | 1997-08-29 | 2001-06-07 | Antigenics Llc | Compositions comprising the adjuvant qs-21 and polysorbate or cyclodextrin as excipient |
| ATE315405T1 (de) * | 1998-08-10 | 2006-02-15 | Antigenics Inc | Cpg-zusammensetzungen, saponin-adjuvantien und verfahren zu deren verwendung |
| EP1104767A1 (en) * | 1999-11-30 | 2001-06-06 | Stichting Dienst Landbouwkundig Onderzoek | Mono- and disaccharide derivatives containing both fatty acid ester and sulfate ester groups |
| AU2002327338A1 (en) * | 2001-07-25 | 2003-02-17 | New York University | Use of glycosylceramides as adjuvants for vaccines against infections and cancer |
| CN1909925B (zh) * | 2004-02-20 | 2010-10-13 | 中国农业大学 | 一种免疫佐剂 |
| JP2008502605A (ja) * | 2004-06-16 | 2008-01-31 | スマート ドラッグ システムズ インコーポレイティド | 徐放性ワクチン組成物 |
| RU2288007C2 (ru) * | 2005-02-17 | 2006-11-27 | ГНУ ВНИИ ветеринарной вирусологии и микробиологии | Способ изготовления ассоциированной инактивированной культуральной вакцины против инфекционного ринотрахеита и парагриппа-3 крупного рогатого скота |
-
2009
- 2009-08-18 TW TW098127794A patent/TW201010719A/zh unknown
- 2009-08-19 EP EP09791663A patent/EP2331126A1/en not_active Withdrawn
- 2009-08-19 AU AU2009282581A patent/AU2009282581B2/en not_active Ceased
- 2009-08-19 CA CA2734654A patent/CA2734654C/en not_active Expired - Fee Related
- 2009-08-19 WO PCT/US2009/054285 patent/WO2010022135A1/en not_active Ceased
- 2009-08-19 BR BRPI0917290A patent/BRPI0917290A8/pt not_active IP Right Cessation
- 2009-08-19 MX MX2011001910A patent/MX2011001910A/es active IP Right Grant
- 2009-08-19 CN CN200980141319.3A patent/CN102186502B/zh not_active Expired - Fee Related
- 2009-08-19 JP JP2011523956A patent/JP2012500282A/ja not_active Ceased
- 2009-08-19 RU RU2011105863/10A patent/RU2506094C2/ru not_active IP Right Cessation
- 2009-08-19 AR ARP090103175A patent/AR076437A1/es not_active Application Discontinuation
- 2009-08-19 UA UAA201101661A patent/UA101385C2/ru unknown
- 2009-08-19 KR KR1020117006189A patent/KR101320141B1/ko not_active Expired - Fee Related
- 2009-08-19 US US12/543,536 patent/US20100047279A1/en not_active Abandoned
-
2011
- 2011-02-23 CO CO11022016A patent/CO6341568A2/es not_active Application Discontinuation
- 2011-03-18 ZA ZA2011/02082A patent/ZA201102082B/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| TW201010719A (en) | 2010-03-16 |
| US20100047279A1 (en) | 2010-02-25 |
| UA101385C2 (ru) | 2013-03-25 |
| AR076437A1 (es) | 2011-06-15 |
| JP2012500282A (ja) | 2012-01-05 |
| MX2011001910A (es) | 2011-06-20 |
| CO6341568A2 (es) | 2011-11-21 |
| BRPI0917290A2 (pt) | 2015-11-10 |
| EP2331126A1 (en) | 2011-06-15 |
| RU2506094C2 (ru) | 2014-02-10 |
| KR101320141B1 (ko) | 2013-11-13 |
| ZA201102082B (en) | 2011-11-30 |
| CN102186502A (zh) | 2011-09-14 |
| AU2009282581B2 (en) | 2013-12-19 |
| AU2009282581A1 (en) | 2010-02-25 |
| WO2010022135A1 (en) | 2010-02-25 |
| CA2734654C (en) | 2015-02-10 |
| RU2011105863A (ru) | 2012-09-27 |
| HK1157182A1 (en) | 2012-06-29 |
| CA2734654A1 (en) | 2010-02-25 |
| CN102186502B (zh) | 2014-07-16 |
| KR20110044791A (ko) | 2011-04-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BRPI0520330A2 (pt) | adjuvante a base de ácido polinosìnico-policitidìlico | |
| MY150706A (en) | Immunogenic substances comprising a polyinosinic acid-polycytidilic acid based adjuvant | |
| BR112022001185A2 (pt) | Método de eliciamento de uma resposta imune administrando uma população de polimerossomos tendo um antígeno associado com uma população de polimerossomos tendo um adjuvante associado, bem como composições compreendendo as duas populações de polimerossomos | |
| CR10348A (es) | Composicion inmunogenica | |
| BR112013005329A2 (pt) | variantes não lipidadas de antígenos orf2086 de neisseria meningitidis | |
| CY1112572T1 (el) | Εμβολια γριπης που περιλαμβανουν συνδυασμους σωματιδιακων ανοσοενισχυτικων και ανοσοδιεγερτες | |
| CO6341568A2 (es) | Composicion inmunologica | |
| BRPI0515316A (pt) | compostos de imidazoquinolina | |
| CO6260103A2 (es) | Composiciones que comprenden antigenos neumococidos | |
| AR052625A1 (es) | Nueva composicion | |
| GT200800172A (es) | Vacuna de mycoplasma hyoneumoniae | |
| BR112012022669A2 (pt) | composição imunogênica, método de tratamento ou prevenção de infecção ou doença, uso de um antígeno, kit, métodos para a fabricação de uma composição imunogênica e para melhorar uma vacina. | |
| CO5700790A2 (es) | Composiciones de vacuna que comprenden una interleucina 18 y sistema de adyuvante de saponina | |
| NO20090062L (no) | Influensavaksine | |
| BR112013009649A2 (pt) | composição imunogênica, métodos para provocar uma resposta imune protetora em um paciente humano e para fornecer proteção imune em seres humanos contra doença, e, uso de uma composição | |
| WO2003009812A3 (en) | Use of glycosylceramides as adjuvants for vaccines against infections and cancer | |
| BR112012027745A2 (pt) | método e composição imunogênica para tratamento de neoplásia | |
| MX2013013906A (es) | Vacunas combinadas para prevencion de infecciones por virus porcino. | |
| BR112013026661A2 (pt) | método de entrega de vacina | |
| BR112015008418A2 (pt) | uso de uma composição imunogênica, composição imunogênica, e, métodos para intensificar atividade opsônica mediada por anticorpo contra um sorotipo alvejado de streptococcus pneumoniae em um indivíduo e para imunizar um hospedeiro humano contra doenças causadas por infecção por streptococcus pneumoniae | |
| MX365726B (es) | Vacuna bacteriana y metodos para la fabricacion de la misma. | |
| BR112016002354A2 (pt) | composição imunogênica, métodos para proteger um bebê contra infecção ou doença e para evocar uma resposta imune, regime de vacinação, e, kit | |
| BR112015032572A2 (pt) | composições e métodos para melhorar o desempenho durante exercícios | |
| BRPI0820960B8 (pt) | composição, composição farmacêutica, e uso da composição | |
| BR112012017202A2 (pt) | composição transparente ou translúcida |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE A 7A ANUIDADE. |
|
| B25A | Requested transfer of rights approved |
Owner name: PAH W LLC (US) |
|
| B25D | Requested change of name of applicant approved |
Owner name: ZOETIS W LLC (US) |
|
| B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2384 DE 13-09-2016 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013. |